Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Immediate Effect of Mobilisation With Movement in Amateur Futsal Athletes With Chronic Ankle Instability

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04699396
Recruitment Status : Completed
First Posted : January 7, 2021
Last Update Posted : March 9, 2021
Sponsor:
Information provided by (Responsible Party):
Alexandre Portela, Escola Superior de Tecnologia da Saúde do Porto

Brief Summary:
Chronic ankle instability (CAI) is an increasingly prevalent condition among futsal athletes. Mobilization with Movement (MWM) is a conservative rehabilitation strategy commonly used in this condition. Even so, the effects of two MWM dorsiflexion techniques on sports performance are not known. The aim is to analyze the immediate effect of two MWM techniques on the dorsiflexion range of motion, the dynamic balance and the performance variables in futsal athletes with CAI. Also, to analyze the impact of performing them in a different order.

Condition or disease Intervention/treatment Phase
Ankle Injuries and Disorders Procedure: Mobilisation With Movement 1 Procedure: Mobilisation With Movement 2 Other: Placebo Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: The Immediate Effect of Two Mobilization With Movement Techniques on Dorsiflexion, Dynamic Balance and Performance Variables, in Futsal Athletes With Chronic Ankle Instability: A Randomized Controlled Trial
Actual Study Start Date : January 14, 2021
Actual Primary Completion Date : February 28, 2021
Actual Study Completion Date : February 28, 2021

Arm Intervention/treatment
Experimental: Mobilisation with Movement 1 (MWM1)
Participants received two ankle dorsiflexion MWM techniques, with glides applied at fibula and talus. Three sets of 10 repetitions of each techniques, were administrated.
Procedure: Mobilisation With Movement 1

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the talus were performed, followed by 3 sets of 10 repetitions of a glide applied to the fibula.

Other Name: Mulligan

Experimental: Mobilisation with Movement 2 (MWM2)
Participants received two ankle dorsiflexion MWM techniques, with glides applied at talus and fibula (order of application inverted). Three sets of 10 repetitions of each techniques, were administrated.
Procedure: Mobilisation With Movement 2

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the fibula were performed, followed by 3 sets of 10 repetitions of a glide applied to the talus.

Other Name: Mulligan

Placebo Comparator: Placebo
The Placebo group participants performed the same number of sets and repetitions of lean/lunge forward into dorsiflexion, without any glide application, in the same position
Other: Placebo
The Placebo group participants performed the same number of sets and repetitions (6 sets of 20 repetitions) of lean/lunge forward into dorsiflexion, without any glide application.

Experimental: Intervention
The experimental groups (MWM1 and MWM2), were later merged into a single Intervention group.
Procedure: Mobilisation With Movement 1

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the talus were performed, followed by 3 sets of 10 repetitions of a glide applied to the fibula.

Other Name: Mulligan

Procedure: Mobilisation With Movement 2

Application of a sustained passive accessory movement to a joint (talus or fibula) while the patient actively performs a forward lean/lunge that was previously limited.

3 sets of 10 repetitions of a glide applied to the fibula were performed, followed by 3 sets of 10 repetitions of a glide applied to the talus.

Other Name: Mulligan




Primary Outcome Measures :
  1. Dorsiflexion range of motion [ Time Frame: Immediate after procedure ]
    The dorsiflexion range of motion (DFROM) of the ankle joint was measured by the Weight-Bearing Lunge Test (WBLT)


Secondary Outcome Measures :
  1. Dynamic balance [ Time Frame: Immediate after procedure ]
    The dynamic balance was measured by the anterior (ANT), posteromedial (PM) and posterolateral (PL) reach directions of the Star Excursion Balance Test (SEBT)

  2. Performance variables [ Time Frame: Immediate after procedure ]
    The performance variables were measured by the time needed to complete the Side Hop Test and the Sprint Test



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. A history of at least one significative ankle sprain:

    • Initial sprain must have occurred at least 12 months prior to study enrolment;
    • Was associated with inflammatory symptoms;
    • Created at least one interrupted day of desired physical activity;
    • The most recent injury must have occurred more than 3 months prior to study enrolment.
  2. A history of the previously injured ankle joint "giving way" and/or recurrent sprain and/or "feelings of instability":

    • Participants should report at least two episodes of "giving way" in the 12 months prior to study enrolment, to account for the seasonal nature of futsal;
    • Recurrent sprain was defined as two or more sprains to the same ankle.
  3. Self-reported ankle instability should be confirmed with the Ankle Instability Instrument: answer "yes" to at least 5 yes/no questions.

Exclusion Criteria:

  1. A history of previous surgeries to the musculoskeletal structures (i.e., bones, joint structures, nerves) in either lower extremity.
  2. A history of bilateral ankle sprain.
  3. A history of a fracture in either lower extremity requiring realignment.
  4. Acute injury to musculoskeletal structures of other joints of the lower extremity in the previous 3 months that impacted joint integrity and function (i.e., sprains, fractures), resulting in at least one interrupted day of desired physical activity.
  5. Have conditions for which manual therapy is generally contraindicated (such as the presence of a tumour, fracture, rheumatoid arthritis, osteoporosis, prolonged history of steroid use, or severe vascular disease).
  6. Receiving concurrent physiotherapy treatment in the last 3 months.
  7. Inability to read Portuguese.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04699396


Locations
Layout table for location information
Portugal
Escola Superior de Saúde do Porto
Porto, Portugal, 4200-072
Sponsors and Collaborators
Escola Superior de Tecnologia da Saúde do Porto
Publications:

Layout table for additonal information
Responsible Party: Alexandre Portela, Principal Investigator, Escola Superior de Tecnologia da Saúde do Porto
ClinicalTrials.gov Identifier: NCT04699396    
Other Study ID Numbers: ESS-MWM
First Posted: January 7, 2021    Key Record Dates
Last Update Posted: March 9, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Ankle Injuries
Leg Injuries
Wounds and Injuries